
The NBM newsletter is back after a
several month hiatus! Thank you for your patience and enjoy.
The
Northwest Behavioral Medicine and Research Center newsletter is back after a
brief hiatus. Thank you for your patience. Dr. Banov has a book called
"Taking Antidepressants" that will be published by Sunrise River
Press and will be available July 2010. Taking Antidepressants is consumer
friendly books helping you decide how and when to start antidepressants, stay
on antidepressants, and stop
"Are
Antidepressants Safe?"
All
medications carry some risks, and antidepressants are no exception. However,
the risks of untreated or inadequately managed depression are far greater than
those of the antidepressants. Fortunately, serious side effects with
antidepressants are rare, but they do occur. You can prevent any significant
problems by knowing what those risks are and what to do should you experience
any such problems.
Government
regulatory agencies, such as the U.S. Food and Drug Administration (FDA)
require that new medications go through a rigorous scientific review process to
assess their overall effectiveness and safety. Pharmaceutical research studies
only give us a narrow picture of a medication’s true risks and benefits,
because the number of patients participating in these studies is relatively
small, and the studies are usually short in duration. Pharmaceutical companies
are required to continually collect information about any serious problems
associated with a medicine after it is approved for general use and make that
information available to doctors and patients. Some very popular medications
have been pulled from the market for safety reasons because of this reporting
system.
Pharmaceutical
companies are required to warn patients and doctors of all possible medication
risks. These companies are held liable if there is a possible link between a
medication and a bad side effect that they did not adequately inform the public
about. This explains why more than half of a 30-second television advertisement
for a medication is devoted to listing all the possible side effects you could
experience. These monitoring and warning systems are far more sophisticated
than in the past and should give you some sense of comfort about any medication
you take.
People have
more concerns about the safety of antidepressants than they do about medicines
used to treat most other medical illnesses. Some of these concerns are
generated by the occasional unsubstantiated news story about the
overprescribing of antidepressants, the dangers associated with these
medications, and pharmaceutical companies’ betraying the public trust by hiding
safety data. Antidepressants provide easy targets for attention-grabbing news
stories because so many people take these medicines, and there is a long-standing
negative bias about mental health treatment. The slew of unfavorable portrayals
of psychiatric illness and treatment in film and literature reinforce such
biases.
Granted,
there have been mental health treatments in the past, like in all areas of
medicine, which, while well intentioned, had adverse outcomes. Nowadays, there
are far better methods to study new medical therapies and regulatory agencies
provide more aggressive oversight to prevent harmful treatments from being
used. Antidepressants, as a class, are some of the best-studied medications on
the market and have a long track record of being monitored for safety since
their arrival in the late 1950s.
Our next
newsletter will address the following:
· Possible
serious side effects
· Risk of
increased suicidal thoughts, worsening depression, or violence
· Medical
risks associated with antidepressant treatment
· Drug
interactions between antidepressants and other medication
· Long-term
risks of antidepressants
We also have several new medication research studies currently
being conducted:
Treatment-resistant depression
Partial responders to current antidepressant
Post-traumatic Stress Disorder
Alcohol Abuse
Depression
Children and Adolescent Attention Deficit Disorder
As always, studies include evaluation by a board certified
psychiatrist, laboratory, study medicine, and follow up care all provided at no
cost.
Call 770-422-2846 (Marietta) or 678-992-1019 (Alpharetta) for
more details. Visit our website www.psychatlanta.com
or email us at study @nbmedicine .com for more details.
©2010 Northwest Behavioral Medicine.
|